InvestorsHub Logo
Followers 3350
Posts 84729
Boards Moderated 6
Alias Born 10/05/2005

Re: None

Thursday, 03/14/2024 8:14:35 AM

Thursday, March 14, 2024 8:14:35 AM

Post# of 1095
$HUGE FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum
https://accesswire.com/viewarticle.aspx?id=839246&lang=en
Bullish
Bullish